Company chart and information is provided by TradingView based on 15-minute-delayed data.
Chinook Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders.
| Website: | www.chinooktx.com |
| Email: | investors@chinooktx.com |
| Main Phone: | +1 604 343-1552 |
| Address: | 1600 Fairview Avenue E |
| State: | WA |
| City / Town: | Seattle |
| Country: | US |
| Postal Code: | 98102 |
| Exchange: | NGS |
| CEO: | Eric L. Dobmeier |
| Employees: | 96 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2021 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
